CEO pay benchmark · $300M – $2B
Small-cap Pharmaceutical Preparations CEO salary
The median CEO compensation at small-cap companies in the pharmaceutical preparations industry is $5,137,542. That is 50% lower than the median across all pharmaceutical preparations companies in our benchmark.
Median CEO pay
$5.1M
Typical range
$4.0M–$8.1M
Companies
8
Average pay ratio
Not available
Vs. full industry
-50%
Size effect
How this group compares with the full industry
The same compensation measures are shown side by side, so the company-size difference is visible without mixing in another dataset.
| Measure | Small-cap | All Pharmaceutical Preparations |
|---|---|---|
| Companies | 8 | 35 |
| Median CEO pay | $5,137,542 | $10,364,688 |
| Average CEO pay | $6,038,149 | $11,740,936 |
| Middle 50% range | $4.0M–$8.1M | $8.0M–$15.1M |
| Average pay ratio | Not available | 5:1 |
Company appendix
Highest CEO pay in this peer group
Up to ten of the highest-paid CEOs in this benchmark, ordered by total annual compensation. Open any company for its full pay breakdown.
| Company | CEO | Total compensation | Market cap |
|---|---|---|---|
| Pacira BioSciences, Inc.PCRX | Frank Lee | $11.6M | $1.0B |
| PERRIGO Co plcPRGO | Patrick Lockwood-Taylor | $9.0M | $1.4B |
| Sarepta Therapeutics, Inc.SRPT | Douglas S. Ingram | $7.8M | $1.6B |
| Xencor IncXNCR | Bassil I. Dahiyat | $5.5M | $1.5B |
| PHIBRO ANIMAL HEALTH CORPPAHC | Jack C. Bendheim | $4.8M | $1.5B |
| Schrodinger, Inc.SDGR | Ramy Farid | $4.1M | $1.4B |
| ANI PHARMACEUTICALS INCANIP | Nikhil Lalwani | $3.7M | $1.6B |
| COLLEGIUM PHARMACEUTICAL, INCCOLL | Vikram Karnani | $1.7M | $1.1B |
Nearby peer groups